REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 142 filers reported holding REPLIMUNE GROUP INC in Q2 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $770,382 | +8.8% | 85,598 | -1.2% | 0.00% | – |
| Q1 2024 | $707,988 | +278.0% | 86,657 | +290.0% | 0.00% | – |
| Q4 2023 | $187,315 | -50.7% | 22,220 | +0.1% | 0.00% | – |
| Q3 2023 | $379,705 | -8.5% | 22,192 | +24.2% | 0.00% | – |
| Q2 2023 | $414,849 | +20.1% | 17,866 | -8.7% | 0.00% | – |
| Q1 2023 | $345,518 | -86.5% | 19,565 | -79.2% | 0.00% | -100.0% |
| Q4 2022 | $2,562,404 | +331.4% | 94,206 | +173.7% | 0.00% | – |
| Q3 2022 | $594,000 | -0.8% | 34,424 | +0.5% | 0.00% | – |
| Q2 2022 | $599,000 | +14.5% | 34,269 | +11.0% | 0.00% | – |
| Q1 2022 | $523,000 | +56.1% | 30,860 | +149.4% | 0.00% | – |
| Q4 2021 | $335,000 | -16.7% | 12,374 | -8.7% | 0.00% | – |
| Q3 2021 | $402,000 | -91.0% | 13,559 | -88.4% | 0.00% | -100.0% |
| Q2 2021 | $4,487,000 | – | 116,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,838,968 | $41,619,000 | 21.14% |
| Omega Fund Management, LLC | 5,103,455 | $74,567,000 | 19.02% |
| Foresite Capital Management IV, LLC | 1,228,656 | $18,012,000 | 5.09% |
| Foresite Capital Management III, LLC | 779,656 | $11,430,000 | 3.75% |
| BVF INC/IL | 1,724,609 | $25,283,000 | 2.76% |
| Redmile Group, LLC | 2,197,003 | $32,208,000 | 0.91% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 711,770 | $10,435,000 | 0.41% |
| EMERALD ADVISERS, LLC | 693,178 | $10,162,000 | 0.41% |
| Artal Group S.A. | 600,000 | $8,796,000 | 0.36% |
| Polar Capital LLP | 175,000 | $2,566,000 | 0.02% |